Concepedia

Madhulika Shukla

MS

Statistics

Publications

4

Citations

90

H-Index

4

Active since

2019

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dana-Farber Cancer Institute

Cornell University

Kettering University

Madhulika Shukla is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, hematology, and pathology.

Top concepts

Publications per year

2019–2023

4

Publications

4

Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia

Mark B. Geyer, Ellen K. Ritchie, Arati V. Rao et al. · Haematologica · 2020 · 42 citations · Full text

Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy

Shivani Handa, Jeong‐Ok Lee, Andriy Derkach et al. · Blood · 2022 · 19 citations · Full text

Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia

Jae H. Park, Sean M. Devlin, Benjamin H. Durham et al. · NEJM Evidence · 2023 · 18 citations · Full text

, , +16

First Line Chemo-Free Therapy with the BRAF Inhibitor Vemurafenib Combined with Obinutuzumab Is Effective in Patients with Hcl

Jae H. Park, Madhulika Shukla, Jose M. Salcedo et al. · Blood · 2019 · 11 citations

1–4 of 4